Ohio State blood cancer experts are improving outcomes at a new clinic where genetic testing helps raise the chances of vital early diagnoses. The HALT (Hematologic Abnormalities at risk of Leukemia Transformation) Clinic is a state-of-the-art program designed to detect blood cancers at their earliest &mdash; and most treatable &mdash; stages. &ldquo;The goal is to identify patients or people at higher risk of developing leukemia due to inherited or acquired genetic mutations,&rdquo; says Uma Borate, MBBS, the co-director of the clinic. Learn much more about the HALT Clinic, and other ways Ohio State experts are treating blood cancers, on our Cancer-Free World Podcast. Listen via the video player above or on SoundCloud. The innovative clinic is made possible by advances in DNA sequencing, which have allowed physicians and other scientists to identify leukemia and other blood cancers in early stages, along with genetic markers that can indicate increased risk. &ldquo;We&rsquo;ve been able to identify patterns of mutations in families and discover inherited genetic disorders we weren&rsquo;t aware of before,&rdquo; Borate says. While the HALT Clinic is relatively new, its building blocks were in place thanks to the continued efforts of OSUCCC &ndash; James doctors and researchers. &ldquo;I helped bring them together under one roof,&rdquo; Borate says of her role in the clinic&rsquo;s creation. Blood cancers can affect people of all ages, though the majority of patients at the HALT Clinic are 60 or older. Borate considers it her mission to help them make the most of their later years. &ldquo;That&rsquo;s what motivates me,&rdquo; she says. &ldquo;If we can do something proactively and identify early and intervene, they can enjoy these years &mdash; with their grandchildren, traveling &mdash; instead of being in my clinic for treatment.&rdquo; Learn more about leukemia, lymphoma and multiple myeloma, including causes, symptoms and treatment options at Ohio State.